Please Wait.....
Report
AI in Genomics Market By Offering (Hardware, Software, Services), By Technology (Machine Learning, Computer Vision), By Application (Drug Discovery and Development, Precision Medicine, Diagnostics, Others), By End User (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2023-03-01 I 420 Pages I Allied Market Research
The global AI in genomics market was valued at $ 0.34 billion in 2021 and is projected to reach $9.9 billion by 2031, growing at a CAGR of 40.6% from 2022 to 2031.
Genomics is a branch of molecular biology that focuses on the study of the entire genetic material (DNA) of organisms. It involves the analysis of the structure, function, and evolution of genomes, including the identification of genes, their regulatory elements, and how they interact with each other. The field of genomics has grown rapidly over the last few decades due to advances in technology that have made it possible to sequence and analyze DNA more quickly and accurately. With the advent of high-throughput sequencing technologies, it is now possible to sequence entire genomes at a fraction of the cost and time that used to be required earlier. AI in the genomics market refers to the use of artificial intelligence (AI) technologies to support genomic research and applications. With the vast amount of genomic data being generated, AI tools have become increasingly important for analyzing and interpreting this data
The driving factors for AI in the genomics market are advancements in AI technologies, growth in demand for personalized medicine, increase in adoption of genomics in research and healthcare, and rise in investment in AI in genomics.Advancements in AI technologies are the result of the development of machine learning, natural language processing, and deep learning has enabled researchers to analyze and interpret genomic data more accurately and efficiently. As AI technologies continue to improve, their application in genomics is expected to become even more widespread. Personalized medicine involves developing treatment plans tailored to individual patients based on their genomic data. As the demand for personalized medicine continues to grow, the use of AI tools in genomics is becoming increasingly important for identifying genetic variations that may be relevant to a patient's disease or condition. For instance, according to the 2022 report by National Library for Medicine, rheumatoid arthritis and psoriasis as the inflammatory disease, in addition to Alzheimer's disease are diseases having high unmet needs for personalized medicine from the viewpoints of disease mechanisms, diagnostic biomarkers, therapeutic drugs with diagnostic markers and treatment satisfaction.
Furthermore, genomics is becoming an increasingly important tool in both research and healthcare, as it provides important insights into the genetic basis of diseases and other conditions. This is driving the need for more advanced AI tools and technologies to analyze and interpret genomic data.However, factors such as high-cost data quality issues and limited availability of skilled professionals are expected to restrain the growth of AI in the genomics market.
The AI in the genomics market is segmented into offering, technology, application, end-user, and region. Based on offering, the market is segmented into software, services and hardware. By technology, the market is segmented into machine learning and computer vision. By application, the market is segmented into drug discovery & development, precision medicine, diagnostics, and others. By end user, the market is segmented into pharmaceutical and biotech companies, healthcare providers, research centers, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the AI in genomics market are Microsoft, IBM, NVIDIA Corporation, Deep Genomics, DATA4CURE, INC, Freenome holdings, Inc, Thermo fisher scientific, Illumina, Inc., Sophia Genetics, and BenevolentAI.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ai in genomics market analysis from 2021 to 2031 to identify the prevailing ai in genomics market opportunities.
Market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
An in-depth analysis of the ai in genomics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes analysis of the regional as well as global ai in genomics market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Technology
- Machine Learning
- Computer Vision
By Offering
- Hardware
- Software
- Services
By Application
- Drug Discovery and Development
- Precision Medicine
- Diagnostics
- Others
By End User
- Pharmaceutical and Biotech Companies
- Healthcare Providers
- Research Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- IBM Corporation
- Deep Genomics
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Data4Cure, Inc
- BenevolentAI
- Microsoft Corporation
- NVIDIA Corporation (Mellanox Technologies)
- Sophia Genetics
- Freenome Holdings, Inc
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Advancements in AI technologies
3.4.1.2. Rising adoption of genomics in research and healthcare
3.4.1.3. Increase ing demand for personalized medicine
3.4.2. Restraints
3.4.2.1. Limited availability of skilled professionals
3.4.2.2. Data quality issues
3.4.3. Opportunities
3.4.3.1. Development of human aware AI
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: AI IN GENOMICS MARKET, BY OFFERING
4.1. Overview
4.1.1. Market size and forecast
4.2. Hardware
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Software
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: AI IN GENOMICS MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Machine Learning
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Computer Vision
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: AI IN GENOMICS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Drug Discovery and Development
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Precision Medicine
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Diagnostics
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Others
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
CHAPTER 7: AI IN GENOMICS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Pharmaceutical and Biotech Companies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Healthcare Providers
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Research Centers
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: AI IN GENOMICS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Offering
8.2.3. Market size and forecast, by Technology
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Offering
8.2.6.1.3. Market size and forecast, by Technology
8.2.6.1.4. Market size and forecast, by Application
8.2.6.1.5. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Offering
8.2.6.2.3. Market size and forecast, by Technology
8.2.6.2.4. Market size and forecast, by Application
8.2.6.2.5. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Offering
8.2.6.3.3. Market size and forecast, by Technology
8.2.6.3.4. Market size and forecast, by Application
8.2.6.3.5. Market size and forecast, by End User
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Offering
8.3.3. Market size and forecast, by Technology
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Offering
8.3.6.1.3. Market size and forecast, by Technology
8.3.6.1.4. Market size and forecast, by Application
8.3.6.1.5. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Offering
8.3.6.2.3. Market size and forecast, by Technology
8.3.6.2.4. Market size and forecast, by Application
8.3.6.2.5. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Offering
8.3.6.3.3. Market size and forecast, by Technology
8.3.6.3.4. Market size and forecast, by Application
8.3.6.3.5. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Offering
8.3.6.4.3. Market size and forecast, by Technology
8.3.6.4.4. Market size and forecast, by Application
8.3.6.4.5. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Offering
8.3.6.5.3. Market size and forecast, by Technology
8.3.6.5.4. Market size and forecast, by Application
8.3.6.5.5. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Offering
8.3.6.6.3. Market size and forecast, by Technology
8.3.6.6.4. Market size and forecast, by Application
8.3.6.6.5. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Offering
8.4.3. Market size and forecast, by Technology
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Offering
8.4.6.1.3. Market size and forecast, by Technology
8.4.6.1.4. Market size and forecast, by Application
8.4.6.1.5. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Offering
8.4.6.2.3. Market size and forecast, by Technology
8.4.6.2.4. Market size and forecast, by Application
8.4.6.2.5. Market size and forecast, by End User
8.4.6.3. Australia
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Offering
8.4.6.3.3. Market size and forecast, by Technology
8.4.6.3.4. Market size and forecast, by Application
8.4.6.3.5. Market size and forecast, by End User
8.4.6.4. India
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Offering
8.4.6.4.3. Market size and forecast, by Technology
8.4.6.4.4. Market size and forecast, by Application
8.4.6.4.5. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Offering
8.4.6.5.3. Market size and forecast, by Technology
8.4.6.5.4. Market size and forecast, by Application
8.4.6.5.5. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Offering
8.4.6.6.3. Market size and forecast, by Technology
8.4.6.6.4. Market size and forecast, by Application
8.4.6.6.5. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Offering
8.5.3. Market size and forecast, by Technology
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Offering
8.5.6.1.3. Market size and forecast, by Technology
8.5.6.1.4. Market size and forecast, by Application
8.5.6.1.5. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Offering
8.5.6.2.3. Market size and forecast, by Technology
8.5.6.2.4. Market size and forecast, by Application
8.5.6.2.5. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Offering
8.5.6.3.3. Market size and forecast, by Technology
8.5.6.3.4. Market size and forecast, by Application
8.5.6.3.5. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Offering
8.5.6.4.3. Market size and forecast, by Technology
8.5.6.4.4. Market size and forecast, by Application
8.5.6.4.5. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2021
CHAPTER 10: COMPANY PROFILES
10.1. Microsoft Corporation
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. IBM Corporation
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. NVIDIA Corporation (Mellanox Technologies)
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. Deep Genomics
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Key strategic moves and developments
10.5. Data4Cure, Inc
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.6. Freenome Holdings, Inc
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.7. Thermo Fisher Scientific Inc.
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.8. Illumina, Inc.
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. Sophia Genetics
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.10. BenevolentAI
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 02. AI IN GENOMICS MARKET FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 03. AI IN GENOMICS MARKET FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 04. AI IN GENOMICS MARKET FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 05. GLOBAL AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 06. AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY REGION, 2021-2031 ($MILLION)
TABLE 07. AI IN GENOMICS MARKET FOR COMPUTER VISION, BY REGION, 2021-2031 ($MILLION)
TABLE 08. GLOBAL AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 09. AI IN GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 10. AI IN GENOMICS MARKET FOR PRECISION MEDICINE, BY REGION, 2021-2031 ($MILLION)
TABLE 11. AI IN GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. AI IN GENOMICS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. GLOBAL AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 14. AI IN GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2021-2031 ($MILLION)
TABLE 15. AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. AI IN GENOMICS MARKET FOR RESEARCH CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 17. AI IN GENOMICS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 20. NORTH AMERICA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 21. NORTH AMERICA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 22. NORTH AMERICA AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. U.S. AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 24. U.S. AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 25. U.S. AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 26. U.S. AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 27. CANADA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 28. CANADA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 29. CANADA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 30. CANADA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 31. MEXICO AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 32. MEXICO AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 33. MEXICO AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 34. MEXICO AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 35. EUROPE AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 36. EUROPE AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 37. EUROPE AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 38. EUROPE AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 39. EUROPE AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 40. GERMANY AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 41. GERMANY AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 42. GERMANY AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 43. GERMANY AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 44. FRANCE AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 45. FRANCE AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 46. FRANCE AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 47. FRANCE AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 48. UK AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 49. UK AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 50. UK AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 51. UK AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 52. ITALY AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 53. ITALY AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 54. ITALY AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 55. ITALY AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 56. SPAIN AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 57. SPAIN AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 58. SPAIN AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 59. SPAIN AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. REST OF EUROPE AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 63. REST OF EUROPE AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 69. JAPAN AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 70. JAPAN AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 71. JAPAN AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 72. JAPAN AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 73. CHINA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 74. CHINA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 75. CHINA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. CHINA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 77. AUSTRALIA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 80. AUSTRALIA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 81. INDIA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 82. INDIA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 83. INDIA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 84. INDIA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. SOUTH KOREA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 86. SOUTH KOREA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 87. SOUTH KOREA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 88. SOUTH KOREA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 93. LAMEA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 94. LAMEA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 95. LAMEA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 96. LAMEA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 97. LAMEA AI IN GENOMICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 98. BRAZIL AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 99. BRAZIL AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 100. BRAZIL AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 101. BRAZIL AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 102. SAUDI ARABIA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 103. SAUDI ARABIA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 104. SAUDI ARABIA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 105. SAUDI ARABIA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 106. SOUTH AFRICA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 107. SOUTH AFRICA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 108. SOUTH AFRICA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 109. SOUTH AFRICA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 110. REST OF LAMEA AI IN GENOMICS MARKET, BY OFFERING, 2021-2031 ($MILLION)
TABLE 111. REST OF LAMEA AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 112. REST OF LAMEA AI IN GENOMICS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 113. REST OF LAMEA AI IN GENOMICS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 114. MICROSOFT CORPORATION: KEY EXECUTIVES
TABLE 115. MICROSOFT CORPORATION: COMPANY SNAPSHOT
TABLE 116. MICROSOFT CORPORATION: SERVICE SEGMENTS
TABLE 117. MICROSOFT CORPORATION: PRODUCT PORTFOLIO
TABLE 118. MICROSOFT CORPORATION: KEY STRATERGIES
TABLE 119. IBM CORPORATION: KEY EXECUTIVES
TABLE 120. IBM CORPORATION: COMPANY SNAPSHOT
TABLE 121. IBM CORPORATION: SERVICE SEGMENTS
TABLE 122. IBM CORPORATION: PRODUCT PORTFOLIO
TABLE 123. IBM CORPORATION: KEY STRATERGIES
TABLE 124. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): KEY EXECUTIVES
TABLE 125. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): COMPANY SNAPSHOT
TABLE 126. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): PRODUCT SEGMENTS
TABLE 127. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): PRODUCT PORTFOLIO
TABLE 128. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): KEY STRATERGIES
TABLE 129. DEEP GENOMICS: KEY EXECUTIVES
TABLE 130. DEEP GENOMICS: COMPANY SNAPSHOT
TABLE 131. DEEP GENOMICS: SERVICE SEGMENTS
TABLE 132. DEEP GENOMICS: PRODUCT PORTFOLIO
TABLE 133. DEEP GENOMICS: KEY STRATERGIES
TABLE 134. DATA4CURE, INC: KEY EXECUTIVES
TABLE 135. DATA4CURE, INC: COMPANY SNAPSHOT
TABLE 136. DATA4CURE, INC: SERVICE SEGMENTS
TABLE 137. DATA4CURE, INC: PRODUCT PORTFOLIO
TABLE 138. FREENOME HOLDINGS, INC: KEY EXECUTIVES
TABLE 139. FREENOME HOLDINGS, INC: COMPANY SNAPSHOT
TABLE 140. FREENOME HOLDINGS, INC: SERVICE SEGMENTS
TABLE 141. FREENOME HOLDINGS, INC: PRODUCT PORTFOLIO
TABLE 142. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
TABLE 143. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 144. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
TABLE 145. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 146. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 147. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 148. ILLUMINA, INC.: PRODUCT SEGMENTS
TABLE 149. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 150. ILLUMINA, INC.: KEY STRATERGIES
TABLE 151. SOPHIA GENETICS: KEY EXECUTIVES
TABLE 152. SOPHIA GENETICS: COMPANY SNAPSHOT
TABLE 153. SOPHIA GENETICS: PRODUCT SEGMENTS
TABLE 154. SOPHIA GENETICS: SERVICE SEGMENTS
TABLE 155. SOPHIA GENETICS: PRODUCT PORTFOLIO
TABLE 156. BENEVOLENTAI: KEY EXECUTIVES
TABLE 157. BENEVOLENTAI: COMPANY SNAPSHOT
TABLE 158. BENEVOLENTAI: SERVICE SEGMENTS
TABLE 159. BENEVOLENTAI: PRODUCT PORTFOLIO
TABLE 160. BENEVOLENTAI: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. AI IN GENOMICS MARKET, 2021-2031
FIGURE 02. SEGMENTATION OF AI IN GENOMICS MARKET, 2021-2031
FIGURE 03. TOP INVESTMENT POCKETS IN AI IN GENOMICS MARKET (2022-2031)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALAI IN GENOMICS MARKET
FIGURE 10. AI IN GENOMICS MARKET, BY OFFERING, 2021(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR HARDWARE, BY COUNTRY 2021 AND 2031(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR SOFTWARE, BY COUNTRY 2021 AND 2031(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR SERVICES, BY COUNTRY 2021 AND 2031(%)
FIGURE 14. AI IN GENOMICS MARKET, BY TECHNOLOGY, 2021(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY COUNTRY 2021 AND 2031(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR COMPUTER VISION, BY COUNTRY 2021 AND 2031(%)
FIGURE 17. AI IN GENOMICS MARKET, BY APPLICATION, 2021(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY 2021 AND 2031(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR PRECISION MEDICINE, BY COUNTRY 2021 AND 2031(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY 2021 AND 2031(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 22. AI IN GENOMICS MARKET, BY END USER, 2021(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY 2021 AND 2031(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF AI IN GENOMICS MARKET FOR RESEARCH CENTERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 26. AI IN GENOMICS MARKET BY REGION, 2021
FIGURE 27. U.S. AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 28. CANADA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 29. MEXICO AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 30. GERMANY AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 31. FRANCE AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 32. UK AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 33. ITALY AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 34. SPAIN AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 35. REST OF EUROPE AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 36. JAPAN AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 37. CHINA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 38. AUSTRALIA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 39. INDIA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 40. SOUTH KOREA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 41. REST OF ASIA-PACIFIC AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 42. BRAZIL AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 43. SAUDI ARABIA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 44. SOUTH AFRICA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 45. REST OF LAMEA AI IN GENOMICS MARKET, 2021-2031 ($MILLION)
FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 50. COMPETITIVE DASHBOARD
FIGURE 51. COMPETITIVE HEATMAP: AI IN GENOMICS MARKET
FIGURE 52. TOP PLAYER POSITIONING, 2021
FIGURE 53. MICROSOFT CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 54. MICROSOFT CORPORATION.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 55. MICROSOFT CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 56. MICROSOFT CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 57. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 58. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
FIGURE 59. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 60. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 61. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): NET REVENUE, 2020-2022 ($MILLION)
FIGURE 62. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022
FIGURE 63. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 64. NVIDIA CORPORATION (MELLANOX TECHNOLOGIES): REVENUE SHARE BY REGION, 2022 (%)
FIGURE 65. THERMO FISHER SCIENTIFIC INC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 66. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 67. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 68. ILLUMINA, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 69. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 70. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 71. SOPHIA GENETICS: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 72. SOPHIA GENETICS: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 73. SOPHIA GENETICS: REVENUE SHARE BY REGION, 2021 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security